RECRUITINGPhase 4INTERVENTIONAL
SUMMIT RISE Study of Acute Ischemic Stroke Patients
SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.
About This Trial
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Who May Be Eligible (Plain English)
Who May Qualify:
- Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
- willing to sign a consent form completed and documented within 72 hours following thrombectomy procedure
- Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
- Age ≥ 18 years
Who Should NOT Join This Trial:
- None
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
* Informed consent completed and documented within 72 hours following thrombectomy procedure
* Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
* Age ≥ 18 years
Exclusion Criteria:
* None
Treatments Being Tested
DEVICE
Route 92 Medical Reperfusion Systems
Mechanical thrombectomy with the Route 92 Medical Reperfusion Systems
Locations (1)
Route 92 Medical, Inc.
West Jordan, Utah, United States